Loading, please wait....jpg)
.jpg)
The Premier December 19, 2023 CE webinar will be held from 12 - 1 pm EST. We are pleased to provide one (1) 60-minute application-based, ACPE-accredited CE activity to pharmacists.
REVERSAL OF DIRECT FACTOR-XA INHIBITORS, AN EVIDENCE UPDATE
SPEAKER: Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP, Anticoagulation Stewardship Director, PGY-2 Thrombosis and Hemostasis Management Residency Program Director, Sanford USD Medical Center, Sioux Falls, SD
ACPE Universal Activity Number 0122-0000-23-064-L01-P [0.1 CEU] [1 Contact Hr.] (Application-based CE)
Date: Dec 19, 2023 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Dec 19, 2023 12:10 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Registration closes on Dec 19, 2023
at 12:10 PM
Registration Closed
Objectives
- Describe current reversal strategies for direct factor-Xa inhibitors, and the theory behind them
- Identify critical real-world evidence that has evolved in this practice space, including strengths and weaknesses of the data
- Compare and contrast the prospective trials than have been conducted with andexanet alfa
- When presented with a patient with a major bleed on a direct factor-Xa inhibitor, determine an appropriate management strategy
Speaker(s)/Author(s)
|
Michael P. Gulseth, PharmD, BCPS, FMSHP, FASHP
|